X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 03/Sep 04:40

TRIMTECH Therapeutics establishes Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the formation of its Scientific Advisory Board (SAB).

Articles similaires

Sorry! Image not available at this time

Immunic to Participate in Investor and Scientific Conferences in September

wn.com - 04/Sep 12:29

Issuer: Immunic AG / Key word(s): Conference 04.09.2025 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement....

Sorry! Image not available at this time

Immunic to Participate in Investor and Scientific Conferences in September

wn.com - 04/Sep 12:29

Issuer: Immunic AG / Key word(s): Conference 04.09.2025 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement....

Sorry! Image not available at this time

Quince Therapeutics to Host Virtual Investor Day on October 2, 2025

wn.com - 12/Sep 00:35

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated...

Sorry! Image not available at this time

Quince Therapeutics to Host Virtual Investor Day on October 2, 2025

wn.com - 12/Sep 00:35

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated...

Sorry! Image not available at this time

Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

mangaloremirror.com - 05/Sep 10:58

BOSTON and LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel...

Sorry! Image not available at this time

Karyopharm Therapeutics completes enrollment in phase 3 SENTRY trial in myelofibrosis

pharmabiz.com - 11/Sep 13:06

Karyopharm Therapeutics Inc., a commercial─stage pharmaceutical company pioneering novel cancer therapies, announced that it has completed...

Sorry! Image not available at this time

Karyopharm Therapeutics completes enrollment in phase 3 SENTRY trial in myelofibrosis

pharmabiz.com - 11/Sep 13:06

Karyopharm Therapeutics Inc., a commercial─stage pharmaceutical company pioneering novel cancer therapies, announced that it has completed...

Sorry! Image not available at this time

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target

mangaloremirror.com - 03/Sep 11:55

PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company...

Sorry! Image not available at this time

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target

mangaloremirror.com - 03/Sep 11:55

PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company...

Sorry! Image not available at this time

Bicycle Therapeutics Strengthens Board of Directors with New Appointments

wn.com - 09/Sep 00:44

Roger Dansey, M.D., formerly Pfizer and Seagen, and Hervé Hoppenot, of Incyte and formerly Novartis Oncology, bring extensive drug development and...

Les derniers communiqués